Fig. 8.
Fig. 8. Probability of survival according to cytogenetic subgroup following treatment with IA, FA, or TA regimens. / Kaplan-Meier estimates of the proportion of patients with inv(16) or t(8;21) (A), normal karyotype (B), −5/−7 (C), and other abnormal karyotypes (D) who remain alive following treatment with IA, FA, or TA regimens.

Probability of survival according to cytogenetic subgroup following treatment with IA, FA, or TA regimens.

Kaplan-Meier estimates of the proportion of patients with inv(16) or t(8;21) (A), normal karyotype (B), −5/−7 (C), and other abnormal karyotypes (D) who remain alive following treatment with IA, FA, or TA regimens.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal